Menu
Currency
GWAS Study

Genome-Wide Association Study of MKI67 Expression and its Clinical Implications in HBV-Related Hepatocellular Carcinoma in Southern China.

Yang CK, Yu TD, Han CY et al.

28700999 PubMed ID
GWAS Study Type
292 Participants
53 Views
Scroll to explore
Chapter I

Publication Details

Comprehensive information about this research publication

Authors

YC
Yang CK
YT
Yu TD
HC
Han CY
QW
Qin W
LX
Liao XW
YL
Yu L
LX
Liu XG
ZG
Zhu GZ
SH
Su H
LS
Lu SC
CZ
Chen ZW
LZ
Liu Z
HK
Huang KT
LZ
Liu ZT
LY
Liang Y
HJ
Huang JL
MZ
Mo ZN
QX
Qin X
LL
Li L
XK
Xiao KY
PM
Peng MH
WC
Winkle CA
OS
O'Brien SJ
PT
Peng T
Chapter II

Abstract

Summary of the research findings

Background/aims: Hepatocellular carcinoma (HCC) is a common malignant tumor with a high rate of recurrence. Immunohistochemical analysis of the marker of proliferation Ki-67 (MKI67) is used to assess proliferation activity of HCC The regulation of MKI67 expression remains unclear in HCC This study aims to explore the association between MKI67 expression and gene variants.

195 Han Chinese ancestry cases

Chapter III

Study Statistics

Key metrics and study information

292
Total Participants
GWAS
Study Type
Yes
Replicated
97 Han Chinese ancestry cases
Replication Participants
East Asian
Ancestry
China
Recruitment Country
Chapter IV

AI-Generated Summary

AI-generated by DNAGENICS

Independent AI summary of health and genetic findings from the published study

Important: This summary is AI-generated by DNAGENICS for informational purposes only. It was not created by, affiliated with, or endorsed by the researchers behind the original publication, and is based solely on that published research. It may contain errors or omissions. DNAGENICS disclaims all liability for any inaccuracies or consequences arising from use of this information. Verify all information against the original publication. This is not professional scientific review or medical advice.

AI Summary In Progress

Our AI-generated summary of this publication is being prepared. Please check back soon.